Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2025-12-25 @ 10:13 PM
NCT ID:
NCT00700258
Recruitment Details:
Data from eligible participants diagnosed with metastatic renal cell carcinoma (mRCC), relapsed or refractory mantle cell lymphoma (MCL) or gastrointestinal stromal tumors (GIST) and who were treated with temsirolimus, sunitinib and/or axitinib, as per routine clinical practice from January 2008 to December 2021 were observed in this prospective, non-interventional, STAR-TOR registry study.
Study:
NCT00700258
Study Brief:
Results Section:
NCT00700258